These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5899549)

  • 1. [Tuberculoid regression in lepromatous leprosy].
    Languillon J
    Bull Soc Pathol Exot Filiales; 1965; 58(5):780-8. PubMed ID: 5899549
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Kveim test in leprosy.
    Krishnamurthy S; Verghese R; Job CK
    Int J Lepr Other Mycobact Dis; 1975; 43(4):333-8. PubMed ID: 1241690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does isopathic phenomenon occur in leprosy?
    Lal S; Natarajan S; Veliath AJ; Garg BR
    Lepr India; 1983 Jul; 55(3):495-9. PubMed ID: 6656207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison in leprosy patients of Fernandex and Mitsuda reactions using human and armadillo antigens. A double-blind study.
    Millar JW; Gannon C; Chan CS
    Int J Lepr Other Mycobact Dis; 1975; 43(3):226-33. PubMed ID: 1240871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies in leprosy. III-Cutaneous response to antigens in spectrum of leprosy.
    Singh PK; Ratna ; Jain PK; Mital VP
    Indian J Lepr; 1984; 56(2):257-63. PubMed ID: 6548495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the 48-hour reaction to Mitsuda antigen. Use of a soluble antigen from human and armadillo lepromin.
    Convit J; Pinardi ME; Avila JL; Aranzazu N
    Bull World Health Organ; 1975; 52(2):187-91. PubMed ID: 1083306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous responses to antigens and irritants in patients of leprosy.
    Kumar B; Kaur S; Ganguly NK; Sharma S
    Lepr India; 1980 Jul; 52(3):405-10. PubMed ID: 7206636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies towards the standardization of lepromin. Progress and prospects.
    Hanks JH; Nakayama T; Abe M; Tuma M; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):703-9. PubMed ID: 5311057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment: Positive Mitsuda lepromin reaction in long-term treated lepromatous leprosy and tuberculoid relapse in lepromatous leprosy.
    Walter J
    Lepr Rev; 1991 Dec; 62(4):434-6. PubMed ID: 1845302
    [No Abstract]   [Full Text] [Related]  

  • 12. Suppressor T lymphocytes from lepromatous leprosy skin lesions.
    Modlin RL; Mehra V; Wong L; Fujimiya Y; Chang WC; Horwitz DA; Bloom BR; Rea TH; Pattengale PK
    J Immunol; 1986 Nov; 137(9):2831-4. PubMed ID: 2944966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts to convert lepromatous into tuberculoid-type leprosy with blood lymphocyte extracts from sensitized donors.
    Silva C; Lima AO; Andrade LM; Mattos O
    Clin Exp Immunol; 1973 Sep; 15(1):87-92. PubMed ID: 4765722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A placebo controlled clinical trial of transfer factor in lepromatous leprosy.
    Faber WR; Leiker DL; Nengerman IM; Schellekens PT
    Clin Exp Immunol; 1979 Jan; 35(1):45-52. PubMed ID: 371887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs.
    Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC
    Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isopathic phenomenon in lepromatous leprosy. A reappraisal.
    Job CK
    Int J Lepr Other Mycobact Dis; 1969; 37(4):365-71. PubMed ID: 5394257
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulation with corticosteroids and levamisole in leprosy as gauged by in vivo lepromin and in vitro CMI responses.
    Kundu SK; Hazra SK; Chaudhuri SK; Nandy A
    Indian J Lepr; 1985; 57(1):37-57. PubMed ID: 3839826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum factors affecting the cell migration inhibition response to lepromin.
    Fliess EL; Ruibal-Ares B; Braun M
    Int J Lepr Other Mycobact Dis; 1975; 43(4):320-6. PubMed ID: 1241688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to lepromin unaltered by application of zinc to the skin in lepromatous leprosy patients.
    Subramanyam VR
    Lepr Rev; 1986 Mar; 57(1):72-3. PubMed ID: 3702584
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of reactions to human and armadillo lepromins in leprosy.
    Meyers WM; Kvernes S; Binford CH
    Int J Lepr Other Mycobact Dis; 1975; 43(3):218-25. PubMed ID: 1240870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.